HFpEF: Gender Difference in Sacubitril/Valsartan Response Remains Mystery HFpEF: Gender Difference in Sacubitril/Valsartan Response Remains Mystery

It remains unclear why women with heart failure with preserved ejection fraction, but not men, derive impressive clinical benefit from sacubitril/valsartan.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news